The fact that two genes acting in the same intracellular signalling pathway are modulated in a consistent direction (Figure 1) strongly supports the importance of the GHR pathway in this GBM subgroup, representing up to 30% of cases. The gene discussed is GHR; the disease is glioblastoma.